---
category: news
title: "Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer"
excerpt: "Data from a new study published in NEJM Evidence shows promise for personalized use of short term ADT in men with predominantly intermediate-risk prostate cancer. The study involved ArteraAI, a developer of multimodal artificial intelligence-based predictive and prognostic cancer tests,"
publishedDateTime: 2023-06-30T21:30:00Z
originalUrl: "https://medicalxpress.com/news/2023-06-validates-first-ever-ai-biomarker-androgen.html"
webUrl: "https://medicalxpress.com/news/2023-06-validates-first-ever-ai-biomarker-androgen.html"
ampWebUrl: "https://medicalxpress.com/news/2023-06-validates-first-ever-ai-biomarker-androgen.amp"
cdnAmpWebUrl: "https://medicalxpress-com.cdn.ampproject.org/c/s/medicalxpress.com/news/2023-06-validates-first-ever-ai-biomarker-androgen.amp"
type: article
quality: 55
heat: 65
published: false

provider:
  name: Medical Xpress
  domain: medicalxpress.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://scx2.b-cdn.net/gfx/news/2021/prostate-cancer-2.jpg"
    width: 740
    height: 444
    isCached: true

related:
  - title: "AI Biomarker Approach for Prostate Cancer Therapy Shows Promise for Some Patients"
    excerpt: "Data from a new study validates the first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer."
    publishedDateTime: 2023-07-03T08:45:00Z
    webUrl: "https://www.technologynetworks.com/tn/news/ai-biomarker-approach-for-prostate-cancer-therapy-shows-promise-for-some-patients-375596"
    type: article
    provider:
      name: technologynetworks
      domain: technologynetworks.com
    quality: 49
    images:
      - url: "https://assets.technologynetworks.com/production/dynamic/images/content/375596/ai-biomarker-approach-for-prostate-cancer-therapy-shows-promise-for-some-patients-375596-640x360.jpg?cb=20230703"
        width: 640
        height: 360
        isCached: true

secured: "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;g6e2bnOVDxuBK2fl/sx++A=="
---

